Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tiffany K. Pon"'
Publikováno v:
Hospital Pharmacy. 57:425-434
Objective: To describe pharmacy resident perspectives on the layered learning practice model (LLPM) at large academic medical centers in the United States and identify the types of training residents receive to prepare for the LLPM. Methods: This was
Autor:
Mimi Lo, Frank Oley, Richard Fong, Tiffany K. Pon, Mary McGann, Ila M Saunders, Angela Lee, Anjlee Mahajan, Shanna Block
Publikováno v:
Thrombosis Research. 208:148-155
Introduction Patients with central nervous system malignancies have limited representation in studies evaluating DOACs for VTE treatment. This study evaluated the safety and efficacy of DOACs in comparison with LMWH for cancer-associated VTE in patie
Autor:
Denise M. Roach, Vincent Cagonot, Laurel Finta, Natalie Wessel, Tiffany K. Pon, Ronnie Delmonte
Publikováno v:
International Journal of Clinical Pharmacy. 41:264-271
Background Pregnancy-related venous thromboembolism (VTE) is a leading preventable cause of maternal mortality in the United States; however, American guidelines for pharmacologic VTE prophylaxis remain less aggressive than other developed countries.
Autor:
Heather Hofmann, Anthony Bejjani, Ian Jenkins, Alpesh Amin, Digish Shah, Anjlee Mahajan, Richard H. White, Tiffany K. Pon, Vineet Gupta, Aaron S. Rosenberg
Publikováno v:
Journal of Thrombosis and Thrombolysis. 45:536-542
Making a definitive diagnosis of heparin-induced thrombocytopenia (HIT) can be problematic. A prompt platelet rise following treatment has been proposed as a "post-test" criterion for diagnosis. However, the platelet response following discontinuatio
Autor:
Mary McGann, Mimi Lo, Frank Oley, Angela Lee, Richard Fong, Shanna Block, Tiffany K. Pon, Ila M Saunders, Anjlee Mahajan
Publikováno v:
Blood. 136:6-6
Background: Management of venous thromboembolism (VTE) in patients with central nervous system (CNS) malignancies is challenging as there is an increased risk of recurrent VTE and intracranial hemorrhage (ICH). Low molecular weight heparins (LMWH) ha
Preceptor development: Responses to frequently asked questions from preceptors in academic hospitals
Autor:
Frank Chu, Tiffany K. Pon, Joseph J. Halfpap, Holly Phillips, Christy Varughese, Melissa L. Thompson Bastin, Patrick Klem, Angela Dangler, Lucy Stun, Jeffrey T. Fish, Susanne Liewer
Publikováno v:
American Journal of Health-System Pharmacy. 73:e261-e266
Preceptor development continues to be a trending topic within our profession. ASHP’s accreditation standards include requirements for preceptor development, and residency program directors continue to seek novel and unique methods for developing pr
Autor:
Tiffany K. Pon, Alan Chuang, Timothy W. Cutler, Jennifer M Branch, Tony D. Huynh, Robert G. Witt, Richard H. White
Publikováno v:
Journal of Managed Care Pharmacy. 20:1028-1034
BACKGROUND: Clinical trials evaluating the efficacy of dabigatran followed a very strict protocol, which included close monitoring and follow-up. Patients followed in this controlled environment had an average medication possession ratio (MPR) > 0.95
Publikováno v:
Thrombosis Research. 133:1023-1028
Background Information regarding dosing of low-molecular-weight heparins (LMWH) for therapeutic anticoagulation in hemodialysis (HD) patients is limited. The aim of this study was to retrospectively compare the safety and efficacy of enoxaparin versu